Identification of intracellular proteins and signaling pathways in human endothelial cells regulated by angiotensin-(1-7)

Journal of Proteomics

Volumn 130, Issue , 2016, Pages 129-139

  Meinert, Christian ^a,b   Gembardt, Florian ^c   Böhme, Ilka ^d   Tetzner, Anja ^b,d   Wieland, Thomas ^a   Greenberg, Barry ^e   Walther, Thomas ^a,b,d  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiotensin (1 7); Antibody microarray; Cell signaling; Endothelium; Renin angiotensin system

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN II [3-8]; ANGIOTENSIN III; ANGIOTENSIN V; ANGIOTENSIN VI; ANGIOTENSIN VII; ANTIBODY; CELL PROTEIN; CYTOPLASM PROTEIN; MESSENGER RNA; PIAS2 PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG; ANGIOTENSIN I (1-7); PEPTIDE FRAGMENT; PROTEIN; PROTEOME;

ARTICLE; BIOINFORMATICS; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING; METABOLISM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MICROARRAY; REGULATORY MECHANISM; STIMULATION; UMBILICAL VEIN ENDOTHELIAL CELL; DOWN REGULATION; GENE EXPRESSION REGULATION; PHYSIOLOGY; PROTEOMICS; SIGNAL TRANSDUCTION;

ANGIOTENSIN I; CELL DEATH; CELL SURVIVAL; DOWN-REGULATION; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; PEPTIDE FRAGMENTS; PROTEIN ARRAY ANALYSIS; PROTEINS; PROTEOME; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 84946500198     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2015.09.020     Document Type: Article

References (45)

1. Fyhrquist F., Saijonmaa O. Renin-angiotensin system revisited. J. Intern. Med. 2008, 264:224-236.
2. Carey R.M., Siragy H.M. Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr. Rev. 2003, 24:261-271.
3. Leung P.S., Carlsson P.O. Tissue renin-angiotensin system: its expression, localization, regulation and potential role in the pancreas. J. Mol. Endocrinol. 2001, 26:155-164.
4. Burson J.M., Aguilera G., Gross K.W., Sigmund C.D. Differential expression of angiotensin receptor 1A and 1B in mouse. Am. J. Physiol. 1994, 267:E260-E267.
5. Ardaillou R. Active fragments of angiotensin II: enzymatic pathways of synthesis and biological effects. Curr. Opin. Nephrol. Hypertens. 1997, 6:28-34.
6. Vauquelin G., Michotte Y., Smolders I., Sarre S., Ebinger G., Dupont A., et al. Cellular targets for angiotensin II fragments: pharmacological and molecular evidence. J. Renin-Angiotensin-Aldosterone Syst. 2002, 3:195-204.
7. Wright J.W., Harding J.W. Important role for angiotensin III and IV in the brain renin-angiotensin system. Brain Res. Brain Res. Rev. 1997, 25:96-124.
8. Kerins D.M., Hao Q., Vaughan D.E. Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV. J. Clin. Invest. 1995, 96:2515-2520.
9. Chai S.Y., Fernando R., Peck G., Ye S.Y., Mendelsohn F.A., Jenkins T.A., et al. The angiotensin IV/AT4 receptor. Cell. Mol. Life Sci. 2004, 61:2728-2737.
10. Kramkowski K., Mogielnicki A., Leszczynska A., Buczko W. Angiotensin-(1-9), the product of angiotensin I conversion in platelets, enhances arterial thrombosis in rats. J. Physiol. Pharmacol. 2010, 61:317-324.
11. Ferrario C.M., Chappell M.C., Dean R.H., Iyer S.N. Novel angiotensin peptides regulate blood pressure, endothelial function, and natriuresis. J. Am. Soc. Nephrol. 1998, 9:1716-1722.
12. Ferrario C.M., Chappell M.C. Novel angiotensin peptides. Cell. Mol. Life Sci. 2004, 61:2720-2727.
13. Vickers C., Hales P., Kaushik V., Dick L., Gavin J., Tang J., et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J. Biol. Chem. 2002, 277:14838-14843.
14. Rice G.I., Thomas D.A., Grant P.J., Turner A.J., Hooper N.M. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem. J. 2004, 383:45-51.
15. Loot A.E., Roks A.J., Henning R.H., Tio R.A., Suurmeijer A.J., Boomsma F., et al. Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation 2002, 105:1548-1550.
16. Wang Y., Qian C., Roks A.J., Westermann D., Schumacher S.M., Escher F., et al. Circulating rather than cardiac angiotensin-(1-7) stimulates cardioprotection after myocardial infarction. Circ. Heart Fail. 2010, 3:286-293.
17. Tallant E.A., Ferrario C.M., Gallagher P.E. Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H1560-H1566.
18. Strawn W.B., Ferrario C.M., Tallant E.A. Angiotensin-(1-7) reduces smooth muscle growth after vascular injury. Hypertension 1999, 33:207-211.
19. Santos R.A., Simoes e Silva A.C., Magaldi A.J., Khosla M.C., Cesar K.R., Passaglio K.T., et al. Evidence for a physiological role of angiotensin-(1-7) in the control of hydroelectrolyte balance. Hypertension 1996, 27:875-884.
20. Rodgers K.E., Espinoza T., Felix J., Roda N., Maldonado S., diZerega G. Acceleration of healing, reduction of fibrotic scar, and normalization of tissue architecture by an angiotensin analogue, NorLeu3-A(1-7). Plast. Reconstr. Surg. 2003, 111:1195-1206.
21. Hellner K., Walther T., Schubert M., Albrecht D. Angiotensin-(1-7) enhances LTP in the hippocampus through the G-protein-coupled receptor Mas. Mol. Cell. Neurosci. 2005, 29:427-435.
22. Heringer-Walther S., Eckert K., Schumacher S.M., Uharek L., Wulf-Goldenberg A., Gembardt F., et al. Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo. Haematologica 2009, 94:857-860.
23. Gallagher P.E., Tallant E.A. Inhibition of human lung cancer cell growth by angiotensin-(1-7). Carcinogenesis 2004, 25:2045-2052.
24. Menon J., Soto-Pantoja D.R., Callahan M.F., Cline J.M., Ferrario C.M., Tallant E.A., et al. Angiotensin-(1-7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2. Cancer Res. 2007, 67:2809-2815.
25. Rodgers K.E., Oliver J., diZerega G.S. Phase I/II dose escalation study of angiotensin 1-7 [A(1-7)] administered before and after chemotherapy in patients with newly diagnosed breast cancer. Cancer Chemother. Pharmacol. 2006, 57:559-568.
26. Santos R.A., Simoes e Silva A.C., Maric C., Silva D.M., Machado R.P., de Buhr I., et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:8258-8263.
27. Verano-Braga T., Schwammle V., Sylvester M., Passos-Silva D.G., Peluso A.A., Etelvino G.M., et al. Time-resolved quantitative phosphoproteomics: new insights into angiotensin-(1-7) signaling networks in human endothelial cells. J. Proteome Res. 2012, 11:3370-3381.
28. Gembardt F., Grajewski S., Vahl M., Schultheiss H.P., Walther T. Angiotensin metabolites can stimulate receptors of the Mas-related genes family. Mol. Cell. Biochem. 2008, 319:115-123.
29. Hodgkinson V.C., ElFadl D., Drew P.J., Lind M.J., Cawkwell L. Repeatedly identified differentially expressed proteins (RIDEPs) from antibody microarray proteomic analysis. J. Proteome 2011, 74:698-703.
30. Petrak J., Ivanek R., Toman O., Cmejla R., Cmejlova J., Vyoral D., et al. Deja vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins. Proteomics 2008, 8:1744-1749.
31. Mariman E.C. 2DE-proteomics meta-data indicate the existence of distinct cellular stress-responsive mechanisms. Expert Rev. Proteomics 2009, 6:337-339.
32. Cook K.L., Metheny-Barlow L.J., Tallant E.A., Gallagher P.E. Angiotensin-(1-7) reduces fibrosis in orthotopic breast tumors. Cancer Res. 2010, 70:8319-8328.
33. Agarwal V., Hodgkinson V.C., Eagle G.L., Scaife L., Lind M.J., Cawkwell L. Proteomic (antibody microarray) exploration of the molecular mechanism of action of the specific COX-2 inhibitor DuP 697. Int. J. Oncol. 2013, 42:1088-1092.
34. Simara P., Koutna I., Stejskal S., Krontorad P., Rucka Z., Peterkova M., et al. Combination of mRNA and protein microarray analysis in complex cell profiling. Neoplasma 2009, 56:141-149.
35. Smith L., Watson M.B., O'Kane S.L., Drew P.J., Lind M.J., Cawkwell L. The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays. Mol. Cancer Ther. 2006, 5:2115-2120.
36. Krishnan B., Smith T.L., Dubey P., Zapadka M.E., Torti F.M., Willingham M.C., et al. Angiotensin-(1-7) attenuates metastatic prostate cancer and reduces osteoclastogenesis. Prostate 2013, 73:71-82.
37. Krishnan B., Torti F.M., Gallagher P.E., Tallant E.A. Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1. Prostate 2013, 73:60-70.
38. Soto-Pantoja D.R., Menon J., Gallagher P.E., Tallant E.A. Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor. Mol. Cancer Ther. 2009, 8:1676-1683.
39. Arora T., Liu B., He H., Kim J., Murphy T.L., Murphy K.M., et al. PIASx is a transcriptional co-repressor of signal transducer and activator of transcription 4. J. Biol. Chem. 2003, 278:21327-21330.
40. Rogers R.S., Horvath C.M., Matunis M.J. SUMO modification of STAT1 and its role in PIAS-mediated inhibition of gene activation. J. Biol. Chem. 2003, 278:30091-30097.
41. Kotaja N., Aittomaki S., Silvennoinen O., Palvimo J.J., Janne O.A. ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation. Mol. Endocrinol. 2000, 14:1986-2000.
42. Ling Y., Sankpal U.T., Robertson A.K., McNally J.G., Karpova T., Robertson K.D. Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription. Nucleic Acids Res. 2004, 32:598-610.
43. Shuai K., Liu B. Regulation of gene-activation pathways by PIAS proteins in the immune system. Nat. Rev. Immunol. 2005, 5:593-605.
44. Takahashi K., Taira T., Niki T., Seino C., Iguchi-Ariga S.M., Ariga H. DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor. J. Biol. Chem. 2001, 276:37556-37563.
45. Zheng Y., Zhang L., Jia X., Wang H., Hu Y. Interaction of protein inhibitor of activated STAT 2 (PIAS2) with receptor of activated C kinase 1, RACK1. FEBS Lett. 2012, 586:122-126.